Revenue

Cara Medical's AI-powered CARA System gets FDA approval, promising to revolutionize complex heart procedures with 3D visualization of the conduction system.

A new partnership aims to deliver a seamless, end-to-end security solution for electronics, helping manufacturers meet tough new global regulations.

With $280M in new funding, Beijing's Spirit AI is using real-world 'dirty data' to build a universal robot brain, challenging Google and Tesla.

A new partnership tackles AI's hidden bottleneck, using advanced interconnects to boost AMD-powered cloud performance, reliability, and efficiency.

Digital Turbine hires ex-Microsoft AI VP Ben John as CTO, a strategic move to leverage AI and first-party data in the booming mobile ad-tech market.

For a second year, TradeCentric made The Hackett Group's '50 to Watch' list, highlighting a market shift where seamless integration is now a core growth strategy.

Helm.ai claims its new vision-only AI can achieve urban autonomy, offering automakers a cheaper, scalable path from ADAS to certified Level 4 self-driving.

At Expo West, GELITA unveils advanced collagen solutions, including OPTIBAR®, tackling major challenges in the booming high-protein, low-sugar snack market.

Amid surging demand, Highspring adds key execs and expands to Dublin and Lisbon, signaling a major play in the global professional services market.

A new report reveals why insurance tech remains clunky and confusing. The problem isn't just bad UX—it's a systemic issue costing billions.

Curanex Pharmaceuticals hits a key manufacturing milestone for Phyto-N, a botanical drug with a 30-year history, advancing its quest for FDA approval.

Advantage Solutions overhauls its board, adding heavyweights in capital markets and commercial strategy to navigate a pivotal transformation and retail industry shifts.

After a mixed earnings report, ScanSource's CFO will outline the firm's pivot to recurring revenue and converging tech at a key investor conference.

For the eighth straight year, Magna5 lands on CRN's Elite 150 list, proving its mettle by evolving its cybersecurity, AI, and compliance services.

With 66% of Gen Z learning skills online, the resume is changing. How can employers tell real expertise from noise in a new skill-based economy?

With promising preclinical data and Australian trial approval, Kivu’s KIVU-305 aims to overcome past failures in targeting aggressive solid tumors.

Rgenta Therapeutics unveils a promising oral drug that targets the genetic root of Huntington's, offering a new beacon of hope for patients.

With funding from a mining giant, Finlay Minerals' latest results identify three major drill-ready copper-gold targets in BC's Toodoggone district.

New subgroup data from ITM's COMPETE trial could refine treatment for a tough-to-treat cancer and bolster the company's position in the radiopharma market.

As teen mental health struggles soar, experts offer a new playbook for parents, blending virtual care with timeless advice on connection and support.